CombiMatrix's Q3 Revenues up 68 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – CombiMatrix reported after the close of the market Wednesday that its third-quarter revenues increased 68 percent on an 82 percent rise in diagnostic testing revenue.

The Irvine, Calif.-based firm brought in total revenues of $1 million for the three-month period ended Sept. 30, compared to $603,000 for the third quarter of 2009. Its services revenue for the quarter rose to $924,000 from $507,000 year over year, while product revenue declined to $90,000 from $96,000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.